WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015 .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering unique aspects of the Company's wearable pain relief technology.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will be participating in the one-on-one Benchmark Micro Cap Discovery Conference which will be held at the Palmer House Hilton , Chicago, IL
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell™, the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015 . Quell™ Wearable Pain Relief Device (Photo: Business Wire)
Record diabetes product revenue of $0.8M Progress with over-the-counter wearable device to treat chronic pain DPNCheck ® launch in Japan Overall year-over-year revenue growth of 9% WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), today reported business
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today said it plans to
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported publication of results from a DPNCheck ® study conducted at the Diabetes Research Unit of the Ipswich Hospital NHS Trust in the United Kingdom . The study by Sharma and colleagues titled "Assessment of Diabetic
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D ., Ph.D., NeuroMetrix President and Chief Executive Officer, will participate in the 29 th Annual Meeting of The Japan Society of Diabetic Complications to be held in Tokyo on October 3 and
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the Company's wearable
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep disorders, today announced that Shai N.
